Explore more publications!
Everything Worth Reading
Got News to Share?

Press Releases

New Year’s Resolution: Become an Author with L. Ron Hubbard’s Writers of the Future Online Workshop
Dec. 30, 2025

New Year’s Resolution: Become an Author with L. Ron Hubbard’s Writers of the Future Online Workshop

Neutral EIN Presswire
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
Dec. 30, 2025

The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)

Indeterminate GlobeNewswire, Inc.
The Last Link Launches A Gripping Thriller Where Inheritance Becomes A Deadly Curse
Jan. 26, 2026

The Last Link Launches A Gripping Thriller Where Inheritance Becomes A Deadly Curse

Neutral EIN Presswire
Cloudbreak Pharma Announces Successful End-of-Phase-2 Meeting and Alignment with FDA on Phase 3 Path Forward for CBT-004
Jan. 27, 2026

Cloudbreak Pharma Announces Successful End-of-Phase-2 Meeting and Alignment with FDA on Phase 3 Path Forward for CBT-004

Indeterminate GlobeNewswire, Inc.
Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development
Jan. 27, 2026

Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development

Indeterminate GlobeNewswire, Inc.
Creative Biolabs: Advancing Gene Therapy with Cutting-Edge Viral Vector Analysis
Jan. 28, 2026

Creative Biolabs: Advancing Gene Therapy with Cutting-Edge Viral Vector Analysis

Neutral EIN Presswire
Protein Supplements Market Size to Worth USD 70.24 Billion by 2035 | Towards FnB
Jan. 27, 2026

Protein Supplements Market Size to Worth USD 70.24 Billion by 2035 | Towards FnB

Indeterminate GlobeNewswire, Inc.
Alexander Semenyuk’s 'The Illuminated' Earns National Praise and Literary Recognition
Jan. 23, 2026

Alexander Semenyuk’s 'The Illuminated' Earns National Praise and Literary Recognition

Neutral EIN Presswire
Rakovina Therapeutics Announces Corporate Update Including up to $1.5 Million in New Financing, Leadership Appointments and Debt Restructuring
Jan. 27, 2026

Rakovina Therapeutics Announces Corporate Update Including up to $1.5 Million in New Financing, Leadership Appointments and Debt Restructuring

Indeterminate GlobeNewswire, Inc.
Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR
Jan. 27, 2026

Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR

Indeterminate GlobeNewswire, Inc.
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN
Jan. 27, 2026

Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN

Indeterminate GlobeNewswire, Inc.
Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 23
Jan. 27, 2026

Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 23

Indeterminate GlobeNewswire, Inc.
Poet and Empowered Christian Woman of Faith Nancian Hall Recently Featured on Close Up Radio
Jan. 27, 2026

Poet and Empowered Christian Woman of Faith Nancian Hall Recently Featured on Close Up Radio

Neutral EIN Presswire
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Jan. 27, 2026

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

Indeterminate GlobeNewswire, Inc.
Natural Carotenoids Market Expected to Reach USD 708.03 Million by 2035 Amid Rising Functional Nutrition Trends
Jan. 27, 2026

Natural Carotenoids Market Expected to Reach USD 708.03 Million by 2035 Amid Rising Functional Nutrition Trends

Indeterminate GlobeNewswire, Inc.
Trump Says New “Secret Weapon” Disabled Venezuelan Defenses
Jan. 27, 2026

Trump Says New “Secret Weapon” Disabled Venezuelan Defenses

Indeterminate MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate
Owned By Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

Satellogic and HEO Establish Australia’s First Sovereign Sub-Meter Capability, Through Sale of NewSat-34™, a Legacy In-Orbit Satellite
Jan. 27, 2026

Satellogic and HEO Establish Australia’s First Sovereign Sub-Meter Capability, Through Sale of NewSat-34™, a Legacy In-Orbit Satellite

Indeterminate GlobeNewswire, Inc.
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
Jan. 27, 2026

Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide

Indeterminate GlobeNewswire, Inc.
Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)
Jan. 27, 2026

Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)

Indeterminate GlobeNewswire, Inc.
HeartLung AI-CVD® Investigator Dr. Reza Mirjalili Wins SCCT 2026 Rapid-Fire Award for AI-CVD® Heart Failure Prediction
Jan. 27, 2026

HeartLung AI-CVD® Investigator Dr. Reza Mirjalili Wins SCCT 2026 Rapid-Fire Award for AI-CVD® Heart Failure Prediction

Neutral EIN Presswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions